专利检索 ap:("THE WESTMEAD INSTITUTE FOR MEDICAL RESEARCH" OR "THE UNIVERSITY OF SYDNEY" OR "WESTERN SYDNEY LOCAL HEALTH DISTRICT" OR "NEW SOUTH WALES HEALTH PATHOLOGY") AND inv:"Leighton CLANCY" 第 1 页

1.

发明申请
ADOPTIVE T CELL THERAPY 2 有权

公开(公告)号：US20220226373A1

公开(公告)日：2022-07-21

申请号：US16625443

申请日：2018-06-22

申请人： THE WESTMEAD INSTITUTE FOR MEDICAL RESEARCH , THE UNIVERSITY OF SYDNEY , WESTERN SYDNEY LOCAL HEALTH DISTRICT , NEW SOUTH WALES HEALTH PATHOLOGY

发明人： Emily BLYTH , Leighton CLANCY , David GOTTLIEB , Kenneth MICKLETHWAITE

IPC分类号： A61K35/17 , A61K39/00 , A61K39/12 , A61P31/10 , A61P31/12 , A61P35/00

摘要： The present disclosure relates to compositions comprising isolated T cells, with activity against a fungal antigen, a viral antigen or a tumour antigen, wherein the composition comprises a defined number or defined ratio of T cells. Described herein are compositions comprising at least two populations of T cells, the compositions being suitable for treating various diseases and disorders.